Navigation Links
High-Throughput Cultivation of Bacterial Clones


Culture 192 clones simultaneously with the tempest thermoshaker

Jeff Braman
Stratagene

The tempest thermoshaker and a 96-deep-well round-bottom plate were used to cultivate bacterial clones in a high-throughput format. Early- and mid-log phase rates of bacterial growth were equivalent in aerated and nonaerated wells of the plate. Late-log phase growth rates of bacteria cultured in nonaerated wells were only slightly slower than growth rates measured in aerated wells. Final cell densities in aerated and nonaerated wells were identical. Flask-cultured bacteria demonstrated a slower initial rate of growth compared to plate-cultured bacteria, however, mid-log phase growth and final cell density were equivalent to plate-cultured bacteria. Well-to-well plate contamination was undetectable. Equal quantities of plasmid DNA were recovered from equal volumes of plate- and flask-cultured bacteria sampled at the end of the incubation period.

The Tempest thermoshaker is a compact benchtop incubator and shaker that is used for regulated temperature incubation (0 to 40C) and rotary mixing (200 to 1500 rpm) of multiple samples. The unit is supplied with a holder to accommodate fifty six 1.5-ml tubes. With Stratagenes minitube adapters, the thermoshaker can also hold 0.5- or 0.6-ml tubes. A microplate platform, also available, holds four, 96-well microtiter plates or two, 96-deep-well plates. The latter plates are particularly useful for cultivating bacteria in a high-throughput.

96-Well Plate vs. Flask Cultivation of Bacteria

Growth rates and final cell densities were measured for plate- and flask-cultured Epicurian Coli XL1-Blue bacteria containing the pBluescript plasmid. One ml of LB medium, containing 100 mg/ml ampicillin, was added to each 2-ml well of the 96-well plate. Bacteria were inoculated into alternate wells of the plate at a density of 2 105 cells/ml. The plate was sealed with its flexible plastic lid, which is designed to seal each well to prevent cross contamination. Perforations were made in the lid over the first 48 wells to allow an exchange of gases between the air space above the culture medium and the atmosphere. The 96-deep-well plate was then incubated at 37C in the thermoshaker (600 rpm).

Bacteria at the same cell density were inoculated into a 2-liter flask, which held 1 liter of LB medium containing 100 g/ml ampicillin. The flask was covered with a piece of sterile aluminum foil and incubated in a New Brunswick Scientific Model G25 Series floor incubator-shaker at 300 rpm.

Bacterial growth was monitored at various time points by removing samples from the aerated and nonaerated wells of both the plate and flask, then measuring absorption at 550 nm.1 Bacteria cultured in nonaerated wells of the plate were removed by perforating the plate lid with a hot needle just prior to sampling. This method prevented the need to remove the lid from the plate and introduce air into the nonaerated wells of the plate.

Bacterial Growth Rates

Figure 2 demonstrates equivalent growth rates of bacteria in early- and mid-log phases in aerated and nonaerated wells of the plate. Late-log phase growth rates of bacteria cultured in nonaerated wells were only slightly slower than in aerated wells. Cell densities at the end of the incubation period in aerated and nonaerated wells were identical. Flask-cultured bacteria demonstrated a slower initial rate of growth compared to plate-cultured bacteria; however, mid-log phase growth and final cell density were equivalent to plate-cultured bacteria. No 550-nm absorption above background was observed in noninoculated wells of the plate.

A sample from every well of the plate was streaked onto an LB-ampicillin agar plate with a sterile toothpick and the plate was incubated at 37C for 24 hours. Bacterial growth was observed only from wells initially inoculated with bacteria. Bacterial growth was not observed in samples retrieved from noninoculated wells (data not shown). Therefore, cross contamination to alternate noninoculated wells did not occur in the aerated and nonaerated wells of the plate.

Plasmid Yield from Plate- and Flask-Cultured Bacteria

Plasmid DNA was isolated from 1 ml of plate- (aerated and nonaerated wells) and flask-cultured bacteria collected at the end of the incubation time period using the StrataPrep plasmid miniprep kit. Plasmid DNA yields were equivalent in plate- and flask-cultured bacteria, as judged by gel electrophoresis (Figure 3).

Fig.3

Conclusions

The Tempest thermoshaker allows 192 bacterial clones to be cultivated simultaneously in two, 96-deep-well plates. A special lid seals each well and prevents cross contamination. Bacterial growth rate, final cell density, and plasmid yield are virtually identical in aerated and nonaerated plate- and flask-cultured bacteria. The Tempest thermoshaker is a convenient and valuable tool when high-throughput capability is required.

REFERENCES
  1. Miller, J.H. (1972) Experiments in Molecular Genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. pp. 32-33.


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Innovative Tissue Array Technology for High-Throughput Screening of Gene Expression
2. Highest Possible Transformation Efficiencies for High-Throughput Applications
3. High-Throughput Isolation of Total RNA
4. High-Throughput System Generates Ultra-Pure PCR Products Suitable for All Applications
5. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
6. Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A
7. Mammalian and Bacterial Expression in One Vector
8. Bacterial mRNA Isolation, Fast and Easy
9. Bacterial RNA Isolation From Infected Eukaryotic Hosts
10. Bacterial RNA Isolation From Infected Eukaryotic Hosts
11. Bacterial Whole Genome Array Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: High Throughput Cultivation Bacterial Clones

(Date:12/2/2009)... 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) ... confirmation and dosimetry trial of Cotara® in patients with ... cancer. Cotara is a targeted monoclonal antibody linked ... treatment for GBM. Cotara specifically targets cells at ...
(Date:12/2/2009)... 2 , - ... , Coinciding with the ... Republic is hosting an international conference in Libreville,(Gabon) ... Africa. The,conference will be attended by government and ...
(Date:12/2/2009)... World, an event bringing together the leaders in ... biotech and MEMS, announced the December 11th deadline ... in its 14th year, TechConnect World, in association ... and the Clean Technology and Sustainable Industries Organization ...
(Date:12/2/2009)... announced data presentations on its novel oral JAK2 inhibitor, ... Meeting and Exposition in New Orleans. ,, Data will ... 1 dose-escalation trial of SB1518 detailing its safety, tolerability ... 100 to 600 mg. These doses were administered once ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
... Ala., Dec. 5 BioCryst Pharmaceuticals (Nasdaq: BCRX ... on Forodesine HCl and BCX-4208, and clinical data on BCX-4208 ... and Exposition being held in San Francisco, CA from December ... nucleoside phosphorylase (PNP) inhibitors. , , ...
... Dec. 4 Medivation, Inc.,(Nasdaq: MDVN ) today announced that ... on two panels at the RBC Capital,Markets 2008 Healthcare Conference on Thursday, ... -- "Waging A Battle Against Cancer" from 8:00-8:55 a.m. Eastern Time, ... Time, , ...
... countries , , SEATTLE, and ... and the nonprofit global health organization PATH announced today a ... will initially invest $3 million over 27 months and work ... (VLP) prototype pandemic influenza vaccine. , , ...
Other Biology Technology:BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition 2BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition 3Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 3
(Date:12/2/2009)... to secondhand cigarette smoke have an increased risk of developing ... , Results of this study are published in Cancer ... Association for Cancer Research, as part of a special tobacco ... more than 219,000 Americans will be diagnosed with lung cancer; ...
(Date:12/2/2009)... that people who smoke cigarettes over a long period ... cancer, even after adjusting for other risk factors. ... or to quit as soon as possible," said senior ... epidemiology and surveillance research at the American Cancer Society. ...
(Date:12/2/2009)... People who smoke their first cigarette within minutes after waking ... nicotine when processed by the body, than those who wait ... , "Since cotinine levels appear to reflect the ... smoke immediately after waking may be especially at risk for ...
Breaking Biology News(10 mins):Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Cigarette smoking increases colorectal cancer risk 2Increased nicotine levels detected in those who light-up earlier 2Without Job Stress Retirees Sleep Better 60756 1Without Job Stress Retirees Sleep Better 60756 2SXC Health solutions announces record third quarter financial results 60754 1SXC Health solutions announces record third quarter financial results 60754 2SXC Health solutions announces record third quarter financial results 60754 3SXC Health solutions announces record third quarter financial results 60754 4SXC Health solutions announces record third quarter financial results 60754 5SXC Health solutions announces record third quarter financial results 60754 6SXC Health solutions announces record third quarter financial results 60754 7SXC Health solutions announces record third quarter financial results 60754 8SXC Health solutions announces record third quarter financial results 60754 9SXC Health solutions announces record third quarter financial results 60754 10SXC Health solutions announces record third quarter financial results 60754 11SXC Health solutions announces record third quarter financial results 60754 12SXC Health solutions announces record third quarter financial results 60754 13SXC Health solutions announces record third quarter financial results 60754 14SXC Health solutions announces record third quarter financial results 60754 15SXC Health solutions announces record third quarter financial results 60754 16SXC Health solutions announces record third quarter financial results 60754 17SXC Health solutions announces record third quarter financial results 60754 18SXC Health solutions announces record third quarter financial results 60754 19SXC Health solutions announces record third quarter financial results 60754 20Chelation Therapy Drug Found Safe and Beneficial for Children With Autism 60752 1Chelation Therapy Drug Found Safe and Beneficial for Children With Autism 60752 2
... knockoffs resembling a key thyroid-related hormone are, in certain ... the target receptor, says a new study conducted in ... and Digestive and Kidney Diseases , (NIDDK) and the ... two of the National Institutes of Health (NIH). The ...
... Fatty acids commonly found in dairy products have successfully ... Penn State. The compounds, known as conjugated linoleic acids ... signaling a new way of potentially treating the disease ... found in dairy products such as milk, cheese and ...
... A pediatric research team has used commercially available ... chromosomes to identify small defects that cause genetic ... detect these abnormalities, the new research may lead ... puzzling disorders that lead to mental retardation. , ...
Other Biology News:In drug design, a loose fit may be best bet 2Compound in dairy products targets diabetes 2Speeding the search for elusive chromosomal errors 2Speeding the search for elusive chromosomal errors 3Speeding the search for elusive chromosomal errors 4
... Mouse monoclonal [RET-P1] to Rhodopsin Rhodopsin ... pigment in mammals, birds, amphibians, and reptiles. ... photoreceptor cells in the retina. ... retina. Specificity: This antibody ...
... Stabilizer is an aqueous solution that contains ... chemicals in a PBS buffer (phosphate buffered ... product does not contain a preservative. ... activity of dried protein components in immunoassays ...
...
... analysis software with the DeCypher Engine accelerator cards ... can perform searches like these from your desktop: ... in under 6 days Align BAC-sized ... Use HMM analysis to compare 100,000 sequences to ...
Biology Products: